海洋バイオテクノロジー市場：製品タイプ、供給源、技術、用途、エンドユーザー別-2025-2030年世界予測

海洋バイオテクノロジー市場は、2024年に82億8,000万米ドルと評価され、2025年には88億8,000万米ドル、CAGR 7.51%で成長し、2030年には127億9,000万米ドルに達すると予測されています。

マリンバイオテクノロジーは科学革新の最前線に位置し、海の神秘と先進技術の飛躍的進歩を融合させ、世界で最も差し迫った課題に取り組んでいます。ここ数年、業界の専門家たちは、環境問題、技術の進歩、研究開発への投資の急増が相まって、急速な進化を遂げていることを目の当たりにしてきました。この変革は、創薬や健康への応用だけでなく、環境保全、エネルギー生産、効率的な食糧供給システムをターゲットとする持続可能な産業ソリューションにも新たな道を開いています。

この分野の成長は、持続可能な慣行に対する世界の再注目と深く関わっています。利害関係者は、生物活性化合物や生物材料の未開発の貯蔵庫を提供する海洋生態系の計り知れない可能性を認識しています。政府や民間投資家がこうした海洋資源の探索に多大な資源を投入する中、この分野では微生物学者や化学エンジニアからデータ科学者や政策立案者に至るまで、学際的な専門家同士の協力が活発化しています。こうした才能の融合が強力な相乗効果を生み出し、有望な機会や革新的な製品を生み出し続けています。

本サマリーは、市場の進化を形成するダイナミックな変化を明確にし、主要なセグメンテーション考察と地域動向を明らかにし、競争優位性を確保しようとする業界リーダーに必須の提言を提供することを目的としています。科学的洞察と市場分析の架け橋となる包括的アプローチにより、本概要は海洋バイオテクノロジーにおける新たな道を探るためのイントロダクションであり、また呼びかけでもあります。

海洋バイオテクノロジー市場の変革

近年、マリンバイオテクノロジーにおける競合情勢を再定義するような変革が起きています。分子生物学、データ分析、養殖方法における進歩の合流は、新たなビジネスモデルと研究パラダイムの出現を触媒しました。先駆的な研究は現在、ゲノム解析や培養に依存しない技術に焦点を当て、様々な産業分野に応用可能なユニークな海洋化合物の発見につながっています。急速な技術進歩は、生物学的に活性な水産物の範囲を広げただけでなく、従来のサプライチェーンや製造プロセスを再構築しました。

この進化の原動力となっているのは、古典的な方法論から、培養に依存しない手法と洗練された分離培養法の両方を取り入れた革新的な技術的アプローチへの移行です。このような適応により、海洋生物のより精密な特性評価が可能になり、工業的規模の生産と、以前はアクセスできなかった微生物コロニーの詳細な調査が可能になります。新しいワークフローを採用する機敏性により、市場のプレーヤーは製品の特異性と有効性を高めながら生産コストを最小限に抑えることができるようになり、投資家にとっても開発者にとってもマリンバイオテクノロジーがますます魅力的なものとなっています。

同時に、環境の持続可能性に対する意識の高まりと、環境に配慮したソリューションの経済的要請が、戦略的投資の形を変えています。この分野の変遷は、科学的研究と市場ニーズの理解との思慮深い統合によって特徴付けられ、マリンバイオテクノロジーを画期的なイノベーションのための重要なインキュベーターとして位置付けています。持続可能で健康を増進する製品を求める世界の需要が、研究努力と戦略的パートナーシップを活性化させる中、今後の開発はさらに限界を押し広げることが期待されます。こうした変革的なシフトの統合は、業界内でより効率的、革新的、持続可能なプロセスを目指す活気ある動きを示すものです。

海洋バイオテクノロジー市場の主要セグメンテーション洞察

海洋バイオテクノロジー市場の分析において、詳細なセグメンテーションの洞察は、進展する動向と新たな機会の明確なイメージを提供します。製品タイプに基づいて市場を調査する場合、生物活性化合物と生体材料に大きな注目が集まる。この2つの焦点により、企業は高い有効性を目指して設計された医薬品化合物から、技術的な産業要件を満たす特殊なバイオマテリアルまで、幅広い製品を開発することができます。同様に、供給源に基づくセグメンテーションでは、サンゴと海綿、海洋藻類、海洋菌類、海洋ウイルスにまたがる広範な研究が明らかになりました。これらの天然供給源はそれぞれ、生物活性プロファイルに独自に寄与し、幅広い用途に不可欠な明確な生化学的特性を提供します。

技術に基づく更なる区分は、微生物の単離と培養と並んで、培養に依存しない技術の重要性を強調しています。この二重の視点により、海洋生物の複雑性を捉え、育むのに十分な堅牢性と汎用性を持つ調査手法が保証されます。アプリケーションベースのセグメンテーションを掘り下げると、市場は養殖・漁業、バイオ燃料、創薬、環境衛生・人体衛生、食品供給、工業製品・プロセスなどの領域にわたって調査されています。このような多様な用途は、この分野が現代の産業やライフスタイルの多方面に影響を与える能力を持つことを強調しています。

さらに、エンドユーザーに基づくセグメンテーションでは、化学、化粧品、エネルギー、食品産業、医療・製薬の各分野における市場参入を分類しています。この階層的なセグメンテーションアプローチは、多様な顧客層がどのようにターゲットとされ、サービスを提供されているかを理解する上で重要です。構造化された内訳は、利害関係者が製品と戦略を調整するのに役立つ包括的なビューを提供し、それによって各特定セグメントでの成長とイノベーションを促進します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 海洋生物多様性と保全に関する意識の高まり
    • 海洋生物由来の天然成分に対する消費者の需要の高まり
    • 海洋由来化合物に対する製薬業界の関心の高まり
  • 抑制要因
    • 研究開発にかかる高コスト
  • 機会
    • 新規酵素の発見のための海洋ゲノミクスへの資金提供の増加
    • 海藻由来の環境に優しいバイオ燃料の需要増加
  • 課題
    • 海洋バイオテクノロジーにおける持続可能性と商業的利益のバランス
• 市場セグメンテーション分析
  • 製品タイプ：抗菌性および抗がん性を有する生物活性化合物の増殖選好
  • 応用：養殖業および漁業分野における海洋バイオテクノロジーの重要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 海洋バイオテクノロジー市場：製品タイプ別

• 生理活性化合物
• 生体材料

第7章 海洋バイオテクノロジー市場：ソース別

• サンゴと海綿動物
• 海藻
• 海洋菌類
• 海洋ウイルス

第8章 海洋バイオテクノロジー市場：技術別

• 文化に依存しない技術
• 微生物の分離と培養

第9章 海洋バイオテクノロジー市場：用途別

• 養殖業と漁業
• バイオ燃料
• 創薬
• 環境衛生と人間の健康
• 食糧供給
• 工業製品とプロセス

第10章 海洋バイオテクノロジー市場：エンドユーザー別

• 化学薬品
• 化粧品
• エネルギー
• 食品業界
• 医療・医薬品

第11章 南北アメリカの海洋バイオテクノロジー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の海洋バイオテクノロジー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの海洋バイオテクノロジー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aker BioMarine ASA
• BASF SE
• Benchmark Holdings plc
• Biolchim Group by J.M. Huber Corporation
• BioLume, Inc.
• BlueBioTech GmbH
• Cellana Inc.
• Corbion N.V.
• DSM-Firmenich AG
• Earthrise Nutritionals LLC
• GeoMarine Biotechnologies（P）LTD
• GlycoMar Ltd.
• Marine Biopolymers Ltd.
• Marinova Pty Ltd
• Marshall Marine Products
• Nofima
• oceanBASIS GmbH
• Pharma Mar, S.A.
• PROLUME, LTD
• Seppic S.A.
• The GELITA Group
• Veramaris V.O.F.
• Xanthella Ltd.
• ZIVO Bioscience, Inc.

LIST OF FIGURES

• FIGURE 1. MARINE BIOTECHNOLOGY MARKET MULTI-CURRENCY
• FIGURE 2. MARINE BIOTECHNOLOGY MARKET MULTI-LANGUAGE
• FIGURE 3. MARINE BIOTECHNOLOGY MARKET RESEARCH PROCESS
• FIGURE 4. MARINE BIOTECHNOLOGY MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. MARINE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. MARINE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. MARINE BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MARINE BIOTECHNOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOACTIVE COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CORALS & SPONGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE ALGAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE FUNGI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CULTURE-INDEPENDENT TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ISOLATION & CULTIVATION OF MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY AQUACULTURE & FISHERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL HEALTH & HUMAN HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY FOOD SUPPLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PRODUCTS & PROCESSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ENERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MEDICAL & PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 76. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 167. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 187. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. MARINE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 241. MARINE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

The Marine Biotechnology Market was valued at USD 8.28 billion in 2024 and is projected to grow to USD 8.88 billion in 2025, with a CAGR of 7.51%, reaching USD 12.79 billion by 2030.

Marine Biotechnology stands at the frontier of scientific innovation, blending the mysteries of the sea with advanced technological breakthroughs to address some of the world's most pressing challenges. In recent years, industry experts have witnessed a rapid evolution driven by a combination of environmental imperatives, technological advancements, and a surge in investment in research and development. This transformation has opened new pathways not only for drug discovery and health applications but also for sustainable industrial solutions that target environmental conservation, energy production, and efficient food supply systems.

The sector's growth is deeply intertwined with a renewed global focus on sustainable practices. Stakeholders are recognizing the immense potential of the marine ecosystem, which offers an untapped reservoir of bioactive compounds and biomaterials. As governments and private investors channel significant resources into exploring these oceanic resources, the field has experienced increased collaboration between multidisciplinary experts, ranging from microbiologists and chemical engineers to data scientists and policy makers. This confluence of talents is creating powerful synergies that continue to unveil promising opportunities and innovative products.

This summary is designed to provide clarity on the dynamic changes shaping the market's evolution, highlight key segmentation insights and regional trends, and offer imperative recommendations for industry leaders looking to seize competitive advantages. With a comprehensive approach that bridges scientific insight and market analysis, this overview serves as both an introduction and a call to explore novel avenues in marine biotechnology.

Transformative Shifts in the Marine Biotechnology Landscape

Recent years have seen transformative shifts that redefine the competitive landscape in marine biotechnology. A confluence of advancements in molecular biology, data analytics, and cultivation methods has catalyzed the emergence of new business models and research paradigms. Pioneering studies now focus on genome analysis and culture-independent techniques leading to the discovery of unique marine compounds with applications across various industries. Rapid technological progress has not only widened the scope of biologically active marine products, but it has also restructured traditional supply chains and manufacturing processes.

A driving force behind this evolution is the shift from classical methodologies to innovative technical approaches that incorporate both culture-independent techniques and refined isolation and cultivation methods. Such adaptations allow for more precise characterization of marine organisms, enabling industrial-scale production and in-depth exploration of previously inaccessible microbial colonies. The agility in adopting new workflows has allowed market players to minimize production costs while enhancing product specificity and efficacy, making marine biotechnology an increasingly attractive prospect for investors and developers alike.

Simultaneously, heightened awareness of environmental sustainability and the economic imperatives of green solutions have reshaped strategic investments. This sector's transition is marked by a thoughtful integration of scientific research with an understanding of market needs, positioning marine biotechnology as a crucial incubator for breakthrough innovations. Future developments promise to push the envelope even further, as global demands for sustainable and health-enhancing products galvanize research efforts and strategic partnerships. The integration of these transformative shifts underlines a vibrant movement toward more efficient, innovative, and sustainable processes within the industry.

Key Segmentation Insights in Marine Biotechnology Markets

In analyzing the marine biotechnology market, detailed segmentation insights provide a clear picture of evolving trends and emerging opportunities. When examining the market based on product type, significant attention is drawn to bioactive compounds and biomaterials. This dual focus allows companies to develop products that range from pharmaceutical compounds designed for high efficacy to specialized biomaterials that meet technical industrial requirements. Similarly, the segmentation based on source reveals an expansive study that spans corals and sponges, marine algae, marine fungi, and marine viruses. Each of these natural sources contributes uniquely to the bioactive profile and offers distinct biochemical properties essential for a wide array of applications.

Further segmentation based on technology highlights the importance of culture-independent techniques alongside the isolation and cultivation of microorganisms. This dual perspective ensures that research methodologies are robust and versatile enough to capture and nurture the complexity of marine organisms. Delving into application-based segmentation, the market is studied across domains such as aquaculture and fishery, biofuels, drug discovery, environmental health and human health, food supply, and industrial products and processes. Such a varied application landscape underscores the sector's capacity to influence multiple facets of contemporary industry and lifestyle.

Moreover, the segmentation based on end-user categorizes market engagement across the chemical, cosmetics, energy, food industry, and medical and pharmaceutical fields. This layered segmentation approach is critical in understanding how diverse customer bases are targeted and served. The structured breakdown offers a comprehensive view that helps stakeholders tailor products and strategies, thereby fostering growth and innovation across each specific segment.

Based on Product Type, market is studied across Bioactive Compounds and Biomaterials.

Based on Source, market is studied across Corals & Sponges, Marine Algae, Marine Fungi, and Marine Viruses.

Based on Technology, market is studied across Culture-Independent Techniques and Isolation & Cultivation of Microorganisms.

Based on Application, market is studied across Aquaculture & Fishery, Biofuels, Drug Discovery, Environmental Health & Human Health, Food supply, and Industrial Products & Processes.

Based on End-User, market is studied across Chemical, Cosmetics, Energy, Food Industry, and Medical & Pharmaceutical.

Key Regional Insights Across Global Markets

Geographic analysis plays a pivotal role in understanding the global proliferation of marine biotechnology innovations. The Americas serve as a major hub of research, development, and commercialization, underpinned by robust governmental support and a strong foundation in biotechnological research. The region boasts a dynamic network of academic and private sector collaborators, which fosters a fertile ground for pioneering research and breakthrough compounds.

In Europe, the Middle East and Africa cluster, a tapestry of diverse regulatory environments and innovative research centers, significantly contributes to shaping market dynamics. This geographical segment is characterized by both long-established biotechnological institutes and emerging players who emphasize sustainable practices and environmental conservation. The collective expertise from these regions fuels advances in technology, thereby ensuring that marine biotechnology continues to evolve amidst challenging and variable market conditions.

The Asia-Pacific region also stands out as a rapidly growing market, driven by expansive economic growth and increasing investments in biotechnology infrastructure. This region's cultural emphasis on technological innovation and integration with traditional practices elevates its market stature, positioning it as a key player in leveraging marine resources. With a combination of academic excellence and strong industrial output, Asia-Pacific is charting a course toward unprecedented levels of market penetration. The comparative regional insights help clarify how diverse markets are not only aligned in seeking sustainable solutions but are also continuously influencing the global landscape of marine biotechnology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Market Innovation

A close examination of the major industry players reveals a landscape that is both competitive and collaborative. Prominent companies that are driving innovation in marine biotechnology include Aker BioMarine ASA, BASF SE, and Benchmark Holdings plc. These entities, along with others such as Biolchim Group by J.M. Huber Corporation and BioLume, Inc., are at the forefront of translating research into commercially viable solutions. Other innovators like BlueBioTech GmbH, Cellana Inc., and Corbion N.V. bolster the competitive edge of the sector by continuously introducing technologies and practices that push conventional boundaries.

Further stirring the industry are firms such as DSM-Firmenich AG, Earthrise Nutritionals LLC, and GeoMarine Biotechnologies (P) LTD, whose emphasis on integrated research and sustainable development has reinforced the role of marine biotechnology in modern industry. Companies like GlycoMar Ltd., Marine Biopolymers Ltd., and Marinova Pty Ltd. also contribute significantly with breakthrough innovations that redefine product reliability and performance. Marshall Marine Products, Nofima, and oceanBASIS GmbH add to this dynamic mix by steering innovation through collaborative research and strategic partnerships.

The landscape is also enriched by the contributions of Pharma Mar, S.A., PROLUME, LTD, Seppic S.A., and The GELITA Group, each of which has carved out unique niches across product and application segments. Veramaris V.O.F., Xanthella Ltd., and ZIVO Bioscience, Inc. further round out the profile of companies that are not only responding to current market demands but are also actively shaping the direction of future growth. The robust involvement of these companies demonstrates a comprehensive commitment to advancing sustainable and high-impact marine technologies.

The report delves into recent significant developments in the Marine Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, BASF SE, Benchmark Holdings plc, Biolchim Group by J.M. Huber Corporation, BioLume, Inc., BlueBioTech GmbH, Cellana Inc., Corbion N.V., DSM-Firmenich AG, Earthrise Nutritionals LLC, GeoMarine Biotechnologies (P) LTD, GlycoMar Ltd., Marine Biopolymers Ltd., Marinova Pty Ltd, Marshall Marine Products, Nofima, oceanBASIS GmbH, Pharma Mar, S.A., PROLUME, LTD, Seppic S.A., The GELITA Group, Veramaris V.O.F., Xanthella Ltd., and ZIVO Bioscience, Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are urged to pursue an agile yet strategic approach to meet the evolving challenges and opportunities in marine biotechnology. First, it is imperative to invest in state-of-the-art research infrastructure that leverages both culture-independent techniques and advanced isolation methodologies to fully utilize the genetic and biochemical diversity present in marine organisms. Concurrently, there should be an emphasis on developing integrated data analytics systems to generate actionable insights that blend market expectations with scientific breakthroughs.

Leaders must consider forging collaborative partnerships with academic institutions, research centers, and cross-sector specialists to accelerate product innovation and facilitate technology transfer. Engaging in public-private partnerships can further bolster the developmental ecosystem, ensuring that innovative solutions are not only financially viable but also meet stringent regulatory and sustainability benchmarks. Moreover, companies should align their strategies with the growing global emphasis on green technologies, promotion of environmental health, and sustainable manufacturing practices.

It is also recommended to embark on pilot projects that demonstrate the commercial viability of emerging marine technologies in specific sectors such as drug discovery, biofuels, and industrial processing. These initiatives serve as proof-of-concept and offer a blueprint for scaling up operations while mitigating risks. Furthermore, leaders should continuously upgrade their existing capabilities by adopting a robust risk management framework to navigate regulatory challenges and market volatilities. A strategic focus on customer-centric innovation will help align technological development with evolving consumer needs while securing competitive advantages in a dynamic global marketplace.

Conclusion: Navigating a Transformative Future

The dynamic realm of marine biotechnology is characterized by innovation, sustainability, and a compelling blend of traditional knowledge with modern science. This executive summary has provided a detailed overview of the transformative shifts influencing the industry, underscoring the importance of looking at diverse segmentation insights and regional dynamics. The analysis highlighted how subdivisions by product type, source, technology, application, and end-user collectively paint a picture of a versatile and rapidly evolving sector.

Moreover, regional insights reveal that each market, whether in the Americas, Europe, Middle East and Africa, or Asia-Pacific, brings its own unique strengths and challenges. This geographic diversity underlines the importance of tailored approaches that respect local market environments while harnessing global technological advancements. Furthermore, an in-depth review of key companies illustrates a competitive yet cooperative sector where leaders are not only challenging traditional paradigms but are setting new benchmarks for innovation and sustainability.

In conclusion, a holistic strategy that integrates advanced research, strategic collaborations, and a commitment to sustainable practices is vital for unlocking the full potential of marine biotechnology. While the journey ahead promises significant rewards, investment in talent, technology, and a resilient supply chain will be key for achieving enduring success in this transformative industry.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness about marine biodiversity and conservation
    • 5.1.1.2. Growing consumer demand for natural ingredients sourced from marine life
    • 5.1.1.3. Increasing pharmaceutical interest in marine-derived compounds
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with research and development
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing funding in marine genomics for the discovery of novel enzymes
    • 5.1.3.2. Rising demand for eco-friendly biofuels derived from marine algae
  • 5.1.4. Challenges
    • 5.1.4.1. Balancing sustainability and commercial interests in marine biotechnology
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Proliferating preference for bioactive compounds owing to their antibacterial and anticancer properties
  • 5.2.2. Application: Rising significance of marine biotechnology in aquaculture and fishery sector
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Marine Biotechnology Market, by Product Type

• 6.1. Introduction
• 6.2. Bioactive Compounds
• 6.3. Biomaterials

7. Marine Biotechnology Market, by Source

• 7.1. Introduction
• 7.2. Corals & Sponges
• 7.3. Marine Algae
• 7.4. Marine Fungi
• 7.5. Marine Viruses

8. Marine Biotechnology Market, by Technology

• 8.1. Introduction
• 8.2. Culture-Independent Techniques
• 8.3. Isolation & Cultivation of Microorganisms

9. Marine Biotechnology Market, by Application

• 9.1. Introduction
• 9.2. Aquaculture & Fishery
• 9.3. Biofuels
• 9.4. Drug Discovery
• 9.5. Environmental Health & Human Health
• 9.6. Food supply
• 9.7. Industrial Products & Processes

10. Marine Biotechnology Market, by End-User

• 10.1. Introduction
• 10.2. Chemical
• 10.3. Cosmetics
• 10.4. Energy
• 10.5. Food Industry
• 10.6. Medical & Pharmaceutical

11. Americas Marine Biotechnology Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Marine Biotechnology Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Marine Biotechnology Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Dominican Republic launches first blue biotechnology company
  • 14.3.2. MiAlgae secured GBP 14 million to expand its operations for sustainable Omega-3s
  • 14.3.3. Regenics raised NOK 20.4 million to fund trials for Collex
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aker BioMarine ASA
• 2. BASF SE
• 3. Benchmark Holdings plc
• 4. Biolchim Group by J.M. Huber Corporation
• 5. BioLume, Inc.
• 6. BlueBioTech GmbH
• 7. Cellana Inc.
• 8. Corbion N.V.
• 9. DSM-Firmenich AG
• 10. Earthrise Nutritionals LLC
• 11. GeoMarine Biotechnologies (P) LTD
• 12. GlycoMar Ltd.
• 13. Marine Biopolymers Ltd.
• 14. Marinova Pty Ltd
• 15. Marshall Marine Products
• 16. Nofima
• 17. oceanBASIS GmbH
• 18. Pharma Mar, S.A.
• 19. PROLUME, LTD
• 20. Seppic S.A.
• 21. The GELITA Group
• 22. Veramaris V.O.F.
• 23. Xanthella Ltd.
• 24. ZIVO Bioscience, Inc.